Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
60,783,333
-
Total 13F shares
-
20,684,670
-
Share change
-
+2,652,619
-
Total reported value
-
$1,568,631,975
-
Put/Call ratio
-
20%
-
Price per share
-
$75.84
-
Number of holders
-
105
-
Value change
-
+$198,929,711
-
Number of buys
-
77
-
Number of sells
-
32
Institutional Holders of ARGENX SE - ADR (ARGX) as of Q3 2018
As of 30 Sep 2018,
ARGENX SE - ADR (ARGX) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,684,670 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Redmile Group, LLC, FEDERATED INVESTORS INC /PA/, venBio Select Advisor LLC, BB BIOTECH AG, ORBIMED ADVISORS LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
105
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.